(Press-News.org) JUPITER, FL-- Scientists from the Florida campus of The Scripps Research Institute (TSRI) have found a compound that could counter Parkinson's disease in two ways at once.
In a new study published recently online ahead of print by the journal ACS Chemical Biology, the scientists describe a "dual inhibitor"- two compounds in a single molecule-- that attacks a pair of proteins closely associated with development of Parkinson's disease.
"In general, these two enzymes amplify the effect of each other," said team leader Phil LoGrasso, a TSRI professor who has been a pioneer in the development of JNK inhibitors for the treatment of neurodegenerative diseases. "What we were looking for is a high-affinity, high-selectivity treatment that is additive or synergistic in its effect—a one-two punch."
That could be what they found.
This new dual inhibitor attacks two enzymes—the leucine-rich repeat kinase 2 (LRRK2) and the c-jun-N-terminal kinase (JNK)—pronounced "junk." Genetic testing of several thousand Parkinson's patients has shown that mutations in the LRRK2 gene increase the risk of Parkinson's disease, while JNK has been shown to play an important role in neuron (nerve cell) survival in a range of neurodegenerative diseases. As such, they have become highly viable targets for drugs to treat disorders such as Parkinson's disease.
A dual inhibitor ultimately would be preferred over separate individual JNK and LRRK2 inhibitors because a combination molecule would eliminate complications of drug-drug interactions and the need to optimize individual inhibitor doses for efficacy, the study noted.
Now the team's new dual inhibitor will need to be optimized for potency, high selectivity (which reduces off-target side effects) and bioavailability so it can be tested in animal models of Parkinson's disease.
INFORMATION:
The first author of the study, "A Small Molecule Bidentate-Binding Dual Inhibitor Probe of the LRRK2 and JNK Kinases," is Yangbo Feng of TSRI. Other authors include Jeremy W. Chambers, Sarah Iqbal, Marcel Koenig, HaJeung Park, Lisa Cherry, Pamela Hernandez and Mariana Figuera-Losada. For more information see http://pubs.acs.org/doi/abs/10.1021/cb3006165
The study was supported by the National Institutes of Health grant NS057153.
Scientists design a potential drug compound that attacks Parkinson's disease on 2 fronts
2013-06-20
ELSE PRESS RELEASES FROM THIS DATE:
Total amount of exercise important, not frequency, research shows
2013-06-20
A new study by Queen's University researchers has determined that adults who accumulated 150 minutes of exercise on a few days of the week were not any less healthy than adults who exercised more frequently throughout the week.
Ian Janssen and his graduate student Janine Clarke studied 2,324 adults from across Canada to determine whether the frequency of physical activity throughout the week is associated with risk factors for diabetes, heart disease and stroke.
"The findings indicate that it does not matter how adults choose to accumulate their 150 weekly minutes of ...
Goal of identifying nearly all genetic causes of deafness is within reach
2013-06-20
New Rochelle, NY, June 20, 2013—At least half of all cases of deafness that develop from birth through infancy in developed countries have a genetic basis, as do many cases of later onset progressive hearing loss. To date, at least 1,000 mutations occurring in 64 genes in the human genome have been linked to hearing loss. Next-generation DNA sequencing technologies are enabling the identification of these deafness-causing genetic variants, as described in a Review article in Genetic Testing and Molecular Biomarkers, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers. ...
African-Americans on Medicaid are far less likely to receive living kidney transplants
2013-06-20
WINSTON-SALEM, N.C. – June 20, 2013 – African-Americans with Medicaid as their primary insurance were less likely to receive a living kidney transplant (LKT) than patients with private insurance, according to a new study by researchers at Wake Forest Baptist Medical Center.
The study is published on the Early View online edition of Clinical Transplantation.
"Living kidney transplantation is the optimal treatment for patients with end-stage renal disease, offering the best quality of life and longest survival," said Amber Reeves-Daniel, D.O., assistant professor of nephrology ...
Particle accelerator that can fit on a tabletop opens new chapter for science research
2013-06-20
AUSTIN, Texas — Physicists at The University of Texas at Austin have built a tabletop particle accelerator that can generate energies and speeds previously reached only by major facilities that are hundreds of meters long and cost hundreds of millions of dollars to build.
"We have accelerated about half a billion electrons to 2 gigaelectronvolts over a distance of about 1 inch," said Mike Downer, professor of physics in the College of Natural Sciences. "Until now that degree of energy and focus has required a conventional accelerator that stretches more than the length ...
Herding cancer cells to their death
2013-06-20
June 20, 2013, New York, NY and Oxford, UK — An advanced tumor is a complex ecosystem. Though derived from a single cell, it evolves as it grows until it contains several subspecies of cells that vary dramatically in their genetic traits and behaviors. This cellular heterogeneity is what makes advanced tumors so difficult to treat. Publishing their findings in today's online issue of Cancer Cell, an international team of scientists led jointly by Professors Colin Goding from the Ludwig Institute for Cancer Research who is based at the University of Oxford and José Neptuno ...
Changing ocean temperatures, circulation patterns affecting young Atlantic cod food supply
2013-06-20
Changing ocean water temperatures and circulation patterns have profoundly affected key Northeast U.S. Continental Shelf zooplankton species in recent decades, and may be influencing the recovery of Atlantic cod and other fish stocks in the region.
NOAA researcher Kevin Friedland and colleagues looked at the distribution and abundance of important zooplankton species, sea surface water temperatures, and cod abundance. They found that zooplankton species critical for the survival of Atlantic cod larvae have declined in abundance in the same areas where Atlantic cod stocks ...
Critical seconds saved during brain aneurysm procedure with pre-surgery rehearsal
2013-06-20
VIDEO:
Surgical Theater aims to allow each and every neurosurgeon the ability to "Pre-Live the Future. " The Surgical Rehearsal Platform (SRP) supports a neurosurgeon's goal of providing patients with the best...
Click here for more information.
Surgical Theater's Surgical Rehearsal Platform™ (SRP) provided neurosurgeons the opportunity to rehearse a complicated cerebral case before entering the operating room, saving the surgical team critical seconds on a time-sensitive ...
Why jumping genes don't send us into meltdown
2013-06-20
The study reveals for the first time how the movement and duplication of segments of DNA known as transposons, is regulated. This prevents a genomic meltdown, and instead enables transposons to live in harmony with their hosts — including humans.
Transposons were discovered in the 1940s by Barbara McClintock, who was rewarded in 1983 with the Nobel Prize for Physiology or Medicine. Ancient relics of these 'jumping genes', as they are sometimes called, make up 50 per cent of the DNA in humans. They are characterised as 'jumping' because they can change their position within ...
Elevated gluten antibodies found in children with autism but no link to celiac disease
2013-06-20
NEW YORK, NY (June 20, 2013)—Researchers have found elevated antibodies to gluten proteins of wheat in children with autism in comparison to those without autism. The results also indicated an association between the elevated antibodies and the presence of gastrointestinal symptoms in the affected children. They did not find any connection, however, between the elevated antibodies and celiac disease, an autoimmune disorder known to be triggered by gluten. The results were e-published in the journal PLOS ONE.
Gluten, a group of more than 70 proteins in wheat and related ...
Chlamydia promotes gene mutations
2013-06-20
This news release is available in German. Chlamydia trachomatis is a human pathogen that is the leading cause of bacterial sexually transmitted disease worldwide with more than 90 million new cases of genital infections occurring each year. About 70 percent of women infected with Chlamydia remain asymptomatic and these bacteria can establish chronic infections for months, or even years. Even when it causes no symptoms, Chlamydia can damage a woman's reproductive organs. In addition, standard antibacterial drugs are proving increasingly ineffective in complete eradication, ...